Company / PP&E per Share
Rein Therapeutics, Inc. PP&E per Share History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2024
5-year range
$0.00 / $0.02
FY2020-FY2024
Trend
-95.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share has fluctuated over the past 8 years, ranging from $0.00 in FY2024 to $0.50 in FY2018.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of -60.0%.
Declined from $0.02 to $0.00 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -58.8%
- 5-Year CAGR
- -60.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, pp&e per share decreased 95.1% year-over-year.
- Peak pp&e per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.00 | -95.1% |
| FY2023 | $0.00 | -72.9% |
| FY2022 | $0.02 | +429.0% |
| FY2021 | $0.00 | +441.8% |
| FY2020 | $0.00 | -97.3% |
| FY2019 | $0.02 | -96.0% |
| FY2018 | $0.50 | +39.0% |
| FY2017 | $0.36 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026